Victrex (LON:VCT) Price Target Raised to GBX 1,050

Victrex (LON:VCT) had its price target boosted by Canaccord Genuity Group from GBX 725 to GBX 1,050 in a research note released on Tuesday morning, Marketbeat Ratings reports. Canaccord Genuity Group currently has a buy rating on the stock.

Several other brokerages have also issued reports on VCT. Berenberg Bank boosted their price target on Victrex from GBX 680 to GBX 870 and gave the company a “hold” rating in a research note on Friday, September 11th. Citigroup raised their price objective on Victrex from GBX 700 to GBX 1,000 and gave the stock a “neutral” rating in a research report on Friday, September 11th. JPMorgan Chase & Co. lifted their price objective on Victrex from GBX 625 to GBX 785 and gave the stock a “neutral” rating in a report on Thursday, September 10th. Finally, Jefferies Financial Group reissued a “hold” rating and set a GBX 595 price objective on shares of Victrex in a report on Friday, September 25th. One research analyst has rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of GBX 807.86.

Victrex Stock Down 1.0%

Shares of VCT opened at GBX 914 on Tuesday. The company has a 50-day simple moving average of GBX 862.66 and a 200-day simple moving average of GBX 703.90. The firm has a market capitalization of £796.61 million, a P/E ratio of -40.80, a P/E/G ratio of 1.92 and a beta of 0.82. The company has a debt-to-equity ratio of 21.30, a quick ratio of 1.99 and a current ratio of 2.35. Victrex has a 52 week low of GBX 515 and a 52 week high of GBX 1,024.

Victrex Company Profile

Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.